ArticleBlood and lymphatic cancer : targets and therapy2026

Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy.

Jinjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.